Skip to content
Triangle logo TriangleGet started
← Full study record

NCT02823327 · OUTCOME

Response Rates

Clinical and Genomic Factors for Prognosis of AIDS Primary Effusion Lymphoma · Source last updated 2025-05-11

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
COUNT_OF_PARTICIPANTS
Unit
Participants
Interval / dispersion
Not reported
Time frame
Up to 1 year

What was measured

The number of participants for this outcome measure is 25 participants with baseline characteristics and response evaluation. Since this was a retrospective study, response criteria were not defined. Response determinations as recorded in the medical record by the treating physician were abstracted on each participant for data analysis. Response rates will be reported with 95% confidence intervals (binomial distribution). Descriptive statistics will be used to summarize baseline clinical, histological, and viral characteristics.

Analysis population: Response rates for the first line of therapy were estimated by survival status.

Groups in this outcome

Survival Less Than 2 Years

8 participants with survival less than 2 years

Survival More Than or Equal to 2 Years

17 participants with survival more than or equal to 2 years

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Survival Less Than 2 Years8
Survival More Than or Equal to 2 Years17

Reported measurements

Complete response
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Survival Less Than 2 Years1Not reportedNot reportedNot reportedNot reported
Survival More Than or Equal to 2 Years13Not reportedNot reportedNot reportedNot reported
Partial response
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Survival Less Than 2 Years2Not reportedNot reportedNot reportedNot reported
Survival More Than or Equal to 2 Years2Not reportedNot reportedNot reportedNot reported
Stable disease
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Survival Less Than 2 Years2Not reportedNot reportedNot reportedNot reported
Survival More Than or Equal to 2 Years2Not reportedNot reportedNot reportedNot reported
Progression
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Survival Less Than 2 Years3Not reportedNot reportedNot reportedNot reported
Survival More Than or Equal to 2 Years3Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        1
      2. group Id
        OG001
        value
        13
    title
    Complete response
  2. categories
    1. measurements
      1. group Id
        OG000
        value
        2
      2. group Id
        OG001
        value
        2
    title
    Partial response
  3. categories
    1. measurements
      1. group Id
        OG000
        value
        2
      2. group Id
        OG001
        value
        2
    title
    Stable disease
  4. categories
    1. measurements
      1. group Id
        OG000
        value
        3
      2. group Id
        OG001
        value
        3
    title
    Progression
denoms
  1. counts
    1. group Id
      OG000
      value
      8
    2. group Id
      OG001
      value
      17
    units
    Participants
description
The number of participants for this outcome measure is 25 participants with baseline characteristics and response evaluation. Since this was a retrospective study, response criteria were not defined. Response determinations as recorded in the medical record by the treating physician were abstracted on each participant for data analysis. Response rates will be reported with 95% confidence intervals (binomial distribution). Descriptive statistics will be used to summarize baseline clinical, histological, and viral characteristics.
groups
  1. description
    8 participants with survival less than 2 years
    id
    OG000
    title
    Survival Less Than 2 Years
  2. description
    17 participants with survival more than or equal to 2 years
    id
    OG001
    title
    Survival More Than or Equal to 2 Years
param Type
COUNT_OF_PARTICIPANTS
population Description
Response rates for the first line of therapy were estimated by survival status.
reporting Status
POSTED
time Frame
Up to 1 year
title
Response Rates
type
PRIMARY
unit Of Measure
Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice